BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 402423)

  • 1. Procedure for the isolation of mouse anti H-2 antibodies from complex alloantisera.
    De Waal RM; Koene RA
    J Immunol Methods; 1977; 14(3-4):225-9. PubMed ID: 402423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.
    de Waal RM; Lems SP; Koene RA
    Transplantation; 1979 Jun; 27(6):376-9. PubMed ID: 380077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    Schwartz RH; Fathman CG; Sachs DH
    J Immunol; 1976 Apr; 116(4):929-35. PubMed ID: 56405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantiserum-induced inhibition of immune response gene product function. II. Genetic analysis of target antigens.
    Shevach EM; Green I; Paul WE
    J Exp Med; 1974 Mar; 139(3):679-95. PubMed ID: 4591175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.
    Lems SP; Rijke-Schilder TP; Capel PJ; Koene RA
    Transplantation; 1984 Mar; 37(3):291-6. PubMed ID: 6701959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive allograft enhancement by subclasses of polyclonal antibodies directed toward restricted regions of the major histocompatibility complex.
    Duc HT; Kinsky RG; Voisin GA
    Transplantation; 1982 May; 33(5):492-9. PubMed ID: 6806954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens.
    Pierce CW; Kapp JA; Solliday SM; Dorf ME; Benacerraf B
    J Exp Med; 1974 Oct; 140(4):921-38. PubMed ID: 4610076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantiserum-induced inhibition of immune response gene product function. I. Cellular distribution of target antigens.
    Shevach EM; Paul WE; Green I
    J Exp Med; 1974 Mar; 139(3):661-78. PubMed ID: 4591174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of cell-mediated immunity by hyperimmune alloantiserum: mechanisms and correlation with allograft enhancement.
    Cohen JM; Yang SS; Law LW
    Int J Cancer; 1974 Apr; 13(4):463-77. PubMed ID: 4135340
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of non-H2 antigen(s) which, like Ia antigens, are associated with the Fc receptor of B lymphocytes.
    Dickler HB; Cone JL; Kubicek MT; Sachs DH
    J Exp Med; 1975 Sep; 142(3):796-801. PubMed ID: 1100765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products.
    Lemonnier F; Burakoff SJ; Mescher M; Dorf ME; Benacerraf B
    J Immunol; 1978 May; 120(5):1717-20. PubMed ID: 307020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of murine leukemia viral antigens detected on mouse cells by H-2 alloantisera.
    Milner RJ; Henning R; Edelman GM
    Eur J Immunol; 1976 Sep; 6(9):603-7. PubMed ID: 187431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ia antigens in inbred rats and their relationship to the MLR phenotype.
    Radka SF; Cramer DV; Gill TJ
    J Immunol; 1977 Dec; 119(6):2037-44. PubMed ID: 144165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anti-mouse IgG on some complement-requiring alloantibodies of the mouse.
    Harris TN; Harris S
    J Immunol; 1972 Nov; 109(5):1096-108. PubMed ID: 4627933
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between mouse immunoglobulins and staphylococcal protein A.
    Chalon MP; Milne RW; Vaerman JP
    Scand J Immunol; 1979; 9(4):359-64. PubMed ID: 108802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.